Member Info for Nolupus

Wildbunch,

Exactly

Just because a patent application is published, it won't always be granted.

Between application dates and the 'granted' status many years Can go by ..

One should Hope that they are not awaiting the patents as the whole patent process is very very slow ..

EasyP,

Whilst many are awaiting news from Switzerland,

some are chucking in the towel.

Everyone to their own trades/convictions

Dallo,

Whilst we may rejoice in the recent SP increase from all time lows, the road remains long.

It's been quite a while since the Sp has gone above the benchmark Price on a monthly basis for IMM to receive the full monthly payment from Landstead .

It's also very encouraging that Prof. Muller is still implicated at her ripe young age of 72.

Hopefully we will get some updates on the 'start' of the Lupus trial shortly and that IMM will sign a major commercial deal in the near future.

Supermobileman ,

Once AGAIN, i never said anything about the % of royalties so please don't put words in my moutb !

I did say on numerous occasions today NOT to confuse the Ownership of the IP with the % of royalties due to the CNRS from any revenues !

I also Said, " As far as i know, it's 50/50 OWnership of the patents "

If i am wrong, which IS of course possible , i will of course let thé board know ..

There was nothing misleading in my message of this morning .

The CNRS are still Joint Owners of the IP /patents ...

The fact that they granted exclusive commercial rights to IMM doesn't change that fact..

IMM still needs to collaborate/negociate/ implicate/ the CNRS in any Patent strategy, Is and was the essence of my post this morning

I cannot see what you refer to as misleading or being badly researched or whatever else..

Cauldstream7,

Did you read this part ?

The patents and intellectual property rights to the full Peptide programme are shared jointly by CNRS and Immupharma France SA , a 100% subsidiary of Immupharma plc.

In light of your 'new' found knowledge, do you stand bye Your comment ?

"I don't think you are in a position to lecture people on doing their own research to check on the truth of your unchecked and unresearched statements such as your latest on CNRS and IMM"

Whatever..

Wigwammer,

I am trying to be polite but you are being an as.h.le

When you were complaining this morning that IMM had no or Limited IP protection and therefore no strategy ..

I replied to you that IMM were not alone in deciding on patent protection as they are only Co owners ..

Now , just do your own research before throwing stones !

What a waste of Time and energy

And i stick to that ..supermobileman

50-50 Ownership With the CNRS

Then the CNRS accepted to out license their part to Immupharma for a % of any future revenues.

Anyway, all it takes Anyone IS a few minutes research if they want to DYOR

Just goes to show that nobody wants to know the truth but a lot just want to Bash nolupus but whatever..

Not worth the effort ...

Wigwammer,

Are IMM joint owners of the patents With the CNRS or not ?

Wigwammer,

You continue to dig a hole for yourself..

All you have to do IS read the Imm company reports or just Google it

Wigwammer,

I think my research and knowledge IS quite sufficent but your own may be lacking After many years out of touch.

Throwing stones IS just too easy ...

Cauldstream7,

Can you not read ?

There is a MAJOR difference between PATENT Ownership and licensing agreements and royalties ..

DYOR

Wigwammer,

I personaly Take offense to your 'attacks' on my 'person'

Ownership of the patents and licensing royalties are Two different matters...

Just GO and DO YOUR OWN research before throwing stones !!

Wigwammer,

As far as i am aware, they are joint holders 50/50 With the CNRS...

Wildbunch will surely clarify this :-)

Wigwammer,

Whilst we may agree on certain details ( or lack of )

One should remember that IMM are only one of the joint patent holders .

Machin,

Best of Luck to you here.

I do believe you have found the right entry point but who knows.

As Always said, the COMPANY needs to grow the turn-over , so that shareholders won't need clever Trevor Money ..

Bottom drawer investment for me

Wildbunch,

They may be awaiting on some patent news before concluding any major deal..

Let's wait and see

Wildbunch.

It's Always important to check things for yourself ..

By the way is Tim Ceo or Chairman ?

Just checking ..